UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CALL
D.R. Horton
DHI
$40.8B
| $10.8M | ﹤0.01% |
77,296
-347,900
| -82% | -$58.1M |
|
2952
CALL
Chewy
CHWY
$9.59B
| $10.8M | ﹤0.01% |
322,246
+81,752
| +34% | +$2.54M |
|
2953
Invesco Dorsey Wright Technology Momentum ETF
PTF
$641M
| $10.8M | ﹤0.01% |
148,685
+49,845
| +50% | +$3.54M |
|
2954
Sprinklr
CXM
$1.55B
| $10.8M | ﹤0.01% |
1,275,711
+948,576
| +290% | +$7.58M |
|
2955
IDEAYA Biosciences
IDYA
$3.49B
| $10.8M | ﹤0.01% |
418,485
+278,938
| +200% | +$7.9M |
|
2956
ProShares UltraPro S&P 500
UPRO
$5.6B
| $10.7M | ﹤0.01% |
121,037
+56,714
| +88% | +$5.19M |
|
|
NVO
2957
CALL
Novo Nordisk
NVO
$203B
| $10.7M | ﹤0.01% |
124,718
+120,200
| +2,660% | +$13M |
|
2958
Enovix
ENVX
$929M
| $10.7M | ﹤0.01% |
1,127,382
+580,910
| +106% | +$5.1M |
|
2959
Nuveen Variable Rate Preferred & Income Fund
NPFD
$445M
| $10.7M | ﹤0.01% |
587,110
+179,017
| +44% | +$3.39M |
|
2960
ARS Pharmaceuticals
SPRY
$551M
| $10.7M | ﹤0.01% |
1,012,701
+902,819
| +822% | +$12.6M |
|
|
AIO
2961
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$898M
| $10.7M | ﹤0.01% |
433,247
+4,404
| +1% | +$103K |
|
2962
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
| $10.7M | ﹤0.01% |
1,099,110
+402,179
| +58% | +$3.98M |
|
2963
Warby Parker
WRBY
$3.31B
| $10.7M | ﹤0.01% |
441,234
+237,487
| +117% | +$4.85M |
|
2964
Extreme Networks
EXTR
$3.18B
| $10.7M | ﹤0.01% |
637,691
+363,399
| +132% | +$5.88M |
|
2965
Walker & Dunlop
WD
$1.52B
| $10.7M | ﹤0.01% |
109,715
+71,285
| +185% | +$7.72M |
|
2966
Clearwater Paper
CLW
$369M
| $10.7M | ﹤0.01% |
358,137
+346,984
| +3,111% | +$9.41M |
|
2967
Graham Holdings Company
GHC
$5.06B
| $10.6M | ﹤0.01% |
12,202
+9,806
| +409% | +$8.58M |
|
|
RFMZ
2968
RiverNorth Flexible Municipal Income Fund II
RFMZ
$319M
| $10.6M | ﹤0.01% |
793,954
+192,365
| +32% | +$2.71M |
|
2969
BJ's Restaurants
BJRI
$1.49B
| $10.6M | ﹤0.01% |
302,721
+288,368
| +2,009% | +$10.2M |
|
2970
Maravai LifeSciences
MRVI
$922M
| $10.6M | ﹤0.01% |
1,951,143
+1,717,771
| +736% | +$11.1M |
|
2971
Invesco Municipal Opportunity Trust
VMO
$660M
| $10.6M | ﹤0.01% |
1,092,008
+45,861
| +4% | +$456K |
|
2972
ATS Corp
ATS
$1.99B
| $10.6M | ﹤0.01% |
348,046
+323,512
| +1,319% | +$9.82M |
|
2973
PUT
HSBC
HSBC
$352B
| $10.6M | ﹤0.01% |
214,200
+1,000
| +0.5% | +$46.4K |
|
2974
Cavco Industries
CVCO
$4.45B
| $10.6M | ﹤0.01% |
23,728
-262
| -1% | -$120K |
|
2975
Mercury Insurance
MCY
$5.95B
| $10.6M | ﹤0.01% |
159,150
+68,982
| +77% | +$4.85M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.